Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


PatchXpress 7000A Automated Parallel Patch Clamp System

Product Description
The PatchXpress® 7000A Automated Parallel Patch Clamp System has revolutionized ion channel drug discovery. With over 13 independent peer reviewed scientific publications, the data quality from the PatchXpress 7000A System is considered to be equivalent to conventional patch clamp-or even better, since it eliminates potential operator bias.

The system's rapid compound addition rate (t=10-15 ms) enables the assay of rapidly desensitizing ligand-gated ion channels, such as the a-7 nicotinic acetylcholine receptor. The independent wash station with individual control for each assay well provides virtually unlimited washout of each recording chamber. This enables the removal of excess cells before the procedure, prevents cumulative desensitization of ligand-gated ion channels, and allows addition of multiple test compounds to the same cell if desired. The use of disposable pipette tips prevents any chance of cross contamination between compound additions, and the optional tip re-use function minimizes non-specific binding of compounds to the pipette tips.

The PatchXpress 7000A System has been successfully used on a large and steadily growing number of different cell types and ion channel classes. The highly configurable patch settings in combination with sophisticated monitoring of membrane parameters make it possible to adapt the experimental parameters using PatchXpress Commander to ideally suit a variety of targets. The system software with its intuitive and logical operation receives rave reviews by our customers and features all the functionality a dedicated researcher needs. The software is based on Clampex module in pCLAMP™ Software and will be familiar to every electrophysiologist that has ever used pCLAMP.
Product PatchXpress 7000A Automated Parallel Patch Clamp System
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439
Email: om@moldev.com



Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!